Approach to the Patient With Primary Aldosteronism: Role of Molecular Imaging
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf396 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Ada E D Teo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Medicine, National University Hospital, Singapore 119074, Singapore. Hauptthemen laut MEDLINE: Hyperaldosteronism, Molecular Imaging. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NMRC Transition Award, Singapore.
Abstract (Originalsprache)
A common yet underdiagnosed cause of secondary hypertension, primary aldosteronism (PA) is characterized by excess aldosterone production, causing hypertension with increased risk of cardio-renal-metabolic complications. Accurate and timely localization of the source of aldosterone excess is crucial for management, in the form of curative adrenalectomy for unilateral aldosterone-producing adenoma or medical management for bilateral adrenal hyperplasia. The current diagnostic algorithm involves adrenal vein sampling (AVS) as the current “gold standard” in determining lateralization of aldosterone secretion, but its technical challenges present significant barriers to timely diagnosis and treatment. Recent technological advancements have contributed to the evolution of molecular imaging modalities such as 11C-metomidate positron emission tomography-computed tomography (11C-MTO PET-CT). Improved molecular imaging modalities hold significant potential to complement existing diagnostic pathways and refine treatment strategies for PA. This review evaluates different case scenarios comparing the utility of AVS with 11C-MTO PET-CT, suggesting a practical approach for its interpretation and highlighting the clinical decision-making process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Department of Medicine, National University Hospital, Singapore 119074, Singapore.
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
- Department of Endocrinology, Changi General Hospital, Singapore 529889, Singapore.
- Duke-National University of Singapore (NUS) Medical School, Singapore 169857, Singapore.
- Department of Endocrinology, University Medical Center, Ho Chi Minh City 700000, Vietnam.
- Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore 169854, Singapore.
ORCID-Profile: Ada E D Teo, Hieu T N Tran, Chin Meng Khoo, Ismail Osman, Aaron Kian-Ti Tong, Roger S Y Foo, Troy H Puar
Förderung
- NMRC Transition Award, Singapore
Zitieren
APA
Teo, A. E. D., Tran, H. T. N., Khoo, C. M., Osman, I., Tong, A. K., Foo, R. S. Y., & Puar, T. H. (2025). Approach to the Patient With Primary Aldosteronism: Role of Molecular Imaging. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf396
Vancouver
Teo AED, Tran HTN, Khoo CM, Osman I, Tong AK, Foo RSY, et al. Approach to the Patient With Primary Aldosteronism: Role of Molecular Imaging. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf396
BibTeX
@article{Teo2025,
author = {Teo, Ada E D and Tran, Hieu T N and Khoo, Chin Meng and Osman, Ismail and Tong, Aaron Kian-Ti and Foo, Roger S Y and Puar, Troy H},
title = {Approach to the Patient With Primary Aldosteronism: Role of Molecular Imaging},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf396}
}
EUVIMED